Citations for CA1 pyramidal neurons: effects of Alzheimer (Culmone and Migliore 2012)

Legends: Link to a Model Reference cited by multiple papers


Culmone V, Migliore M (2012) Progressive effect of beta amyloid peptides accumulation on CA1 pyramidal neurons: a model study suggesting possible treatments. Front Comput Neurosci 6:52 [PubMed]

References and models cited by this paper

References and models that cite this paper

Bentwich J, Dobronevsky E, Aichenbaum S, Shorer R, Peretz R, Khaigrekht M, Marton RG, Rabey JM (2011) Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease: a proof of concept study. J Neural Transm (Vienna) 118:463-71 [Journal] [PubMed]
Billings LM, Green KN, McGaugh JL, LaFerla FM (2007) Learning decreases A beta*56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice. J Neurosci 27:751-61 [Journal] [PubMed]
Csicsvari J, Hirase H, Czurkó A, Mamiya A, Buzsáki G (1999) Oscillatory coupling of hippocampal pyramidal cells and interneurons in the behaving Rat. J Neurosci 19:274-87 [PubMed]
Eckert A, Hauptmann S, Scherping I, Rhein V, Müller-Spahn F, Götz J, Müller WE (2008) Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice. Neurodegener Dis 5:157-9 [Journal] [PubMed]
Ferrante M, Blackwell KT, Migliore M, Ascoli GA (2008) Computational models of neuronal biophysics and the characterization of potential neuropharmacological targets. Curr Med Chem 15:2456-71 [PubMed]
  • Computational neuropharmacology of CA1 pyramidal neuron (Ferrante et al. 2008) [Model]
Gasparini S, Migliore M, Magee JC (2004) On the initiation and propagation of dendritic spikes in CA1 pyramidal neurons. J Neurosci 24:11046-56 [Journal] [PubMed]
  • CA1 pyramidal neuron: dendritic spike initiation (Gasparini et al 2004) [Model]
Goedert M (1987) Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease. EMBO J 6:3627-32 [PubMed]
Good TA, Smith DO, Murphy RM (1996) Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons. Biophys J 70:296-304 [Journal] [PubMed]
Hamos JE, DeGennaro LJ, Drachman DA (1989) Synaptic loss in Alzheimer's disease and other dementias. Neurology 39:355-61 [PubMed]
Hasselmo ME (1997) A computational model of the progression of Alzheimer's disease. MD Comput 14:181-91 [PubMed]
Hines ML, Carnevale NT (1997) The NEURON simulation environment. Neural Comput 9:1179-209 [PubMed]
Horn D, Levy N, Ruppin E (1996) Neuronal-based synaptic compensation: a computational study in Alzheimer's disease. Neural Comput 8:1227-43 [PubMed]
Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13:45-53 [PubMed]
Kim DY, Carey BW, Wang H, Ingano LA, Binshtok AM, Wertz MH, Pettingell WH, He P, Lee VM, Woolf CJ, Kovacs DM (2007) BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat Cell Biol 9:755-64 [Journal] [PubMed]
Kloskowska E, Malkiewicz K, Winblad B, Benedikz E, Bruton JD (2008) APPswe mutation increases the frequency of spontaneous Ca2+-oscillations in rat hippocampal neurons. Neurosci Lett 436:250-4 [Journal] [PubMed]
Knobloch M, Mansuy IM (2008) Dendritic spine loss and synaptic alterations in Alzheimer's disease. Mol Neurobiol 37:73-82 [Journal] [PubMed]
Kuchibhotla KV, Lattarulo CR, Hyman BT, Bacskai BJ (2009) Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 323:1211-5 [Journal] [PubMed]
LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8:499-509 [Journal] [PubMed]
MacLean JN, Zhang Y, Goeritz ML, Casey R, Oliva R, Guckenheimer J, Harris-Warrick RM (2005) Activity-independent coregulation of IA and Ih in rhythmically active neurons. J Neurophysiol 94:3601-17 [Journal] [PubMed]
Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15:1437-49 [Journal] [PubMed]
Mattson MP, Chan SL (2001) Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits. J Mol Neurosci 17:205-24 [Journal] [PubMed]
Megías M, Emri Z, Freund TF, Gulyás AI (2001) Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells. Neuroscience 102:527-40 [PubMed]
Migliore M (2003) On the integration of subthreshold inputs from Perforant Path and Schaffer Collaterals in hippocampal CA1 pyramidal neurons. J Comput Neurosci 14:185-92 [PubMed]
  • CA1 pyramidal neuron: integration of subthreshold inputs from PP and SC (Migliore 2003) [Model]
Migliore M, Shepherd GM (2002) Emerging rules for the distributions of active dendritic conductances. Nat Rev Neurosci 3:362-70 [Journal] [PubMed]
  • Modulation of temporal integration window (Migliore, Shepherd 2002) [Model]
Moreira PI, Santos MS, Moreno A, Oliveira C (2001) Amyloid beta-peptide promotes permeability transition pore in brain mitochondria. Biosci Rep 21:789-800 [PubMed]
Morse TM, Carnevale NT, Mutalik PG, Migliore M, Shepherd GM (2010) Abnormal Excitability of Oblique Dendrites Implicated in Early Alzheimer's: A Computational Study. Front Neural Circuits [Journal] [PubMed]
  • Amyloid beta (IA block) effects on a model CA1 pyramidal cell (Morse et al. 2010) [Model]
Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, Litchfield S, Smith A, Barnetson L, Smith AD (1995) Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia 6:21-31 [PubMed]
Palop JJ, Mucke L (2010) Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci 13:812-8 [Journal] [PubMed]
Parameshwaran K, Sims C, Kanju P, Vaithianathan T, Shonesy BC, Dhanasekaran M, Bahr BA, Suppiramaniam V (2007) Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function. Synapse 61:367-74 [Journal] [PubMed]
Perez-Cruz C, Nolte MW, van Gaalen MM, Rustay NR, Termont A, Tanghe A, Kirchhoff F, Ebert U (2011) Reduced spine density in specific regions of CA1 pyramidal neurons in two transgenic mouse models of Alzheimer's disease. J Neurosci 31:3926-34 [Journal] [PubMed]
Plant LD, Webster NJ, Boyle JP, Ramsden M, Freir DB, Peers C, Pearson HA (2006) Amyloid beta peptide as a physiological modulator of neuronal 'A'-type K+ current. Neurobiol Aging 27:1673-83 [Journal] [PubMed]
Ponomareva NV, Korovaitseva GI, Rogaev EI (2008) EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease. Neurobiol Aging 29:819-27 [Journal] [PubMed]
Reddy PH, Beal MF (2008) Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 14:45-53 [Journal] [PubMed]
Rensink AA, de Waal RM, Kremer B, Verbeek MM (2003) Pathogenesis of cerebral amyloid angiopathy. Brain Res Brain Res Rev 43:207-23 [PubMed]
Rowan M (2012) Information-selectivity of Beta-amyloid pathology in an associative memory model. Front Comput Neurosci 6:2 [Journal] [PubMed]
Rui Y, Li R, Liu Y, Zhu S, Yu X, Sheng Z, Xie Z (2006) Acute effect of beta amyloid on synchronized spontaneous Ca2+ oscillations in cultured hippocampal networks. Cell Biol Int 30:733-40 [Journal] [PubMed]
Ruppin E, Reggia JA (1995) A neural model of memory impairment in diffuse cerebral atrophy. Br J Psychiatry 166:19-28 [PubMed]
Sato S, Xu J, Okuyama S, Martinez LB, Walsh SM, Jacobsen MT, Swan RJ, Schlautman JD, Ciborowski P, Ikezu T (2008) Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1. J Neurosci 28:14511-21 [Journal] [PubMed]
Selkoe DJ (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399:A23-31 [PubMed]
Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866-75 [Journal] [PubMed]
Terry RD (2000) Cell death or synaptic loss in Alzheimer disease. J Neuropathol Exp Neurol 59:1118-9 [PubMed]
Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-80 [Journal] [PubMed]
Texidó L, Martín-Satué M, Alberdi E, Solsona C, Matute C (2011) Amyloid ß peptide oligomers directly activate NMDA receptors. Cell Calcium 49:184-90 [Journal] [PubMed]
Wei W, Nguyen LN, Kessels HW, Hagiwara H, Sisodia S, Malinow R (2010) Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nat Neurosci 13:190-6 [Journal] [PubMed]
Zou X, Coyle D, Wong-Lin K, Maguire L (2011) Computational study of hippocampal-septal theta rhythm changes due to ß-amyloid-altered ionic channels. PLoS One 6:e21579 [Journal] [PubMed]
Romani A, Marchetti C, Bianchi D, Leinekugel X, Poirazi P, Migliore M, Marie H (2013) Computational modeling of the effects of amyloid-beta on release probability at hippocampal synapses. Front Comput Neurosci 7:1 [Journal] [PubMed]
  • Amyloid-beta effects on release probability and integration at CA3-CA1 synapses (Romani et al. 2013) [Model]
Spera E, Migliore M, Unsworth N, Tegolo D (2016) On the cellular mechanisms underlying working memory capacity in humans Neural Network World 4:335-359 [Journal]
  • Model of CA1 activity during working memory task (Spera et al. 2016) [Model]
(51 refs)